In patients with NAFLD in which insulin-induced endogenous glucose production was suppressed, impaired insulin-induced suppression of VLDL-TG secretion was observed [58], suggesting that the increase in VLDL-TG secretion may be an early pathophysiological manifestation of NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.